When drugs damage the liver– New podcast out now

Communications / 05 February 2024

The liver, responsible for drug metabolism in the body, is also most at risk of damage due to medicines. Unravel the complexities of DILI and its impact on medication safety.


When it comes to our health, the liver plays a crucial role in processing and detoxifying substances, including medications. However, it can also be badly damaged by medicines and their compounds, resulting in drug-induced liver injury (DILI). In the latest episode of Drug Safety Matters, Rita Baião from the North Lisbon University Hospital Center discusses the complexities of DILI, who is most at risk of developing it, and the proactive measures taken during drug development to mitigate damage.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

You may also like


A week in the name of medicines safety part 2 – New podcast out now

To celebrate #MedSafetyWeek, Drug Safety Matters presents a two-part episode on medicine safety communication campaigns and how they help us spread the pharmacovigilance message.

Communications / 14 November 2023

Patient voices in pharmacovigilance takes centre stage at ISoP Bali 2023

The most recent ISoP event saw hundreds of experts gather to explore the latest innovations and challenges facing pharmacovigilance, with a special focus on patient perspectives.

Communications / 16 January 2024

Patient safety set to gain from new partnership between CDISC and UMC

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

Communications / 20 February 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more